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Abstract
With the increased affordability and availability
of whole-genome sequencing, large-scale and high-
throughput gene expression is widely used to charac-
terize diseases, including cancers. However, establish-
ing specificity in cancer diagnosis using gene expres-
sion data continues to pose challenges due to the high
dimensionality and complexity of the data. Here we
present models of deep learning (DL) and apply them
to gene expression data for the diagnosis and catego-
rization of cancer. In this study, we have developed two
DL models using messenger ribonucleic acid (mRNA)
datasets available from the Genomic Data Commons
repository. Our models achieved 98% accuracy in can-
cer detection, with false negative and false positive rates
below 1.7%. In our results, we demonstrated that 18 out
of 32 cancer-typing classifications achieved more than
90% accuracy. Due to the limitation of a small sample
size (less than 50 observations), certain cancers could
not achieve a higher accuracy in typing classification,
but still achieved high accuracy for the cancer detection
task. To validate our models, we compared them with
traditional statistical models. The main advantage of our
models over traditional cancer detection is the ability
to use data from various cancer types to automatically
form features to enhance the detection and diagnosis of
a specific cancer type.
Introduction
Gene expression profiling technology has led to many signif-
icant biological discoveries. Much of the work built on gene
expression data has focused on correlation between a small
portion of the features from the data and various biological
states and disease states, due to the high dimensionality and
complexity of such data. With recent advances in computa-
tional power (parallel and massive computing on GPUs) and
emergence of high-throughput data analysis and inference
techniques, such as artificial intelligence, machine learning,
and deep learning, fitting high-dimensional data is no longer
the bottleneck of the in silico application of gene expres-
sion data. However, current solutions for disease detection,
especially cancer detection methods, still rely on traditional
feature selection and dimension reduction approaches, i.e.
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finding a small feature space of genes with expression val-
ues sufficiently correlated to the disease states. The assump-
tion is that ignoring features it is assumed do not provide
significant information, allows a reduction in computation
complexity but still allows accurate single-class classifica-
tion.
This assumption misrepresents the mechanism of disease
at system biological level. Models originating from this as-
sumption are unscalable and more than not fail to generalize
across different types of cancers without feature redesign.
In addition, due to the small sample sizes available for in-
dividual cancers, these models cannot take full advantage
of data from different cancer types. Even though many re-
search studies have sought to conquer this issue, the majority
still rely on principle component analysis, a linear statistical
model approach.
To deal with these problems and exceed the limits of the
dimension-reduction paradigm in order to develop a more
generalized model of cancer detection and typing classifica-
tion, we propose in this paper a deep learning approach with-
out the pains of feature space reduction/generation and that
avoids the loss of potentially valuable information. We use
an autoencoder method to learn high-level feature represen-
tations from the whole space of data features. In contrast to
the previous methods, where one model is strictly appropri-
ate for one type of cancer, our method allows typing classi-
fication of multiple cancers. In addition, this model does not
rely on a dimension reduction approach; thus, even data col-
lected from different microarray and RNA-sequencing plat-
forms can still be used for detection and classification.
The remainder of this paper is organized as follows: Sec-
tion 2 provides some background about gene expression and
its data. Section 3 outlines the proposed method and several
statistical models we used for comparison. Section 4 shows
results of our method and compares them to other statistical
learning models, and in Section 5 we discuss the results and
future direction. Finally, Section 6 offers conclusions.
Gene Expression Data
Gene Expression Analysis
Gene expression profiling has been adopted as the stan-
dard tool to measure the level of activity of genes within
a given tissue. Gene expression data capture the amount
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Figure 1: Example gene expression data file.
of messenger ribonucleic acid (mRNA) synthesized during
the cellular transcription, which ultimately will be trans-
lated into proteins. Thus, gene expression is fundamentally
a direct measurement of the cellular functionality(Lockhart
and Winzeler 2000). As cancers are a genetic and regula-
tory disease, cancer cells metabolic activities differ from
those of normal cells, and this will be captured through
gene expression data using microarray or RNA-seq(Perou et
al. 1999). Recently, more and more studies utilize a global
gene-expression profiles of tumor cells and matched normal
cells from the same origin to capture differences in expres-
sion. Though the number of human genes is about 22,000,
gene expression data from the microarray or RNA-seq meth-
ods has a feature (column) number of 60,483, which in-
cludes extra transcriptome informationincluding both mes-
senger or coding RNAs and a variety of non-coding RNAs
(ncRNAs) (Wang, Gerstein, and Snyder 2009).
In biomedical studies, gene expression analysis depends
upon comparing relative proportions of reads; thus, data nor-
malization is the essential and critical preprocessing step to
correct unwanted biological effects, remove technical noise,
and normalize differences between platforms. Three types of
normalization are commonly used: reads per kilobase mil-
lion (RPKM), fragment per kilobase million (FPKM) and
transcripts per million (TPM). TPM is used in this paper to
correct biases in gene length and sequencing depth because
it allows comparison across different replicates (Wagner,
Kin, and Lynch 2012). These values are generated through
this pipeline by first aligning reads to the GRCh38 reference
genome and then by quantifying the mapped reads. After
the preprocessing pipeline, we obtain gene expression data
as a matrix, which contains rows representing observations
(sample) and columns representing features (corresponding
to an array experiment), as shown in Figure 1.
Gene Expression Datasets
All gene expression data in this paper are from the Genomic
Data Commons (GDC), a research program initiated by the
National Cancer Institute (NCI) (The Genomic Data Com-
mons Data Portal). Data are collected from 29 major primary
sites with 32 disease (cancer) types with gene expression
data deposited at the GDC. These cancer types are KICH,
LIHC, DLBC, OV, USC, LGG, THCA, ACC, LUAD,
HNSC, BLCA, MESO, ESCA, UVM. CESC, LUSC, TGCT,
PAAD, SARC, KIRP, UCEX, STAD, PCPG, KIRC, SKCM,
THYM, PRAD, READ, GBM, BRCA, CHOL, and COAD.
Related Work
Many researchers have proposed detecting cancer using
gene expression data. The most fundamental approach is to
use dimension reduction methods, such as PCA, to conduct
feature selection, then apply traditional statistical classifica-
tion methods(Nguyen and Rocke 2002). Other feature selec-
tion approaches include the use of recursive feature elimina-
tion approaches in combination with other filter steps, e.g.,
(1) using univariate association filtering for feature selec-
tion(Aliferis et al. ) and (2) applying SVM to find a small
subset of gene expressions as a new and smaller feature
space(Ramaswamy et al. 2001) that can achieve a similar re-
sult. Want et al. has shown a correlation-based selector com-
bined with machine learning classification methods(Hall
1999; Wang et al. 2005) can achieve accuracy no worse than
that achieved by other methods. A divide-and-conquer ap-
proach can also be used for feature selection: first, divide
genes into smaller spaces, then, from these smaller subset,
select the top-r informative genes, and later merge them into
an informative subset of genes (Sharma, Imoto, and Miyano
2012). The ensemble approach, which also combines dif-
ferent feature dimension reduction methods, must be men-
tioned as well(Nanni et al. ).
The majority of the methods mentioned above focus on
reducing the gene expression dimension, or in a more gen-
eral perspective, the feature generation (here equal to selec-
tion), based on certain criteria. One problem with these ap-
proaches is the limited scalability and generality of the clas-
sification models. Since features are designed, or selected,
through a manual approach, it is almost impossible to apply
the same features to new datasets or different classification
tasks without re-designing, or re-selecting, the features. Be-
cause of this, models built on these features can neither be
used to classify different types of cancers, or take advan-
tage of the datasets from those cancers, since the selected
features are highly correlated to the cancer from which they
were generated(Fakoor et al. 2013). The Pan-Cancer Epige-
netic Biomarker Selection from Blood Samples(Chen, Xie,
and Yuan 2018) demonstrated that multiple cancer classi-
fication can be conduct through analysis of DNA methyla-
tion profiles with accuracy similar to that achieved with sin-
gle classification. This suggests that gene expression profiles
can be applied in a similar fashion by pooling all data and
classifying multiple cancer types.
Methods
In this section, we first introduce the computational config-
uration, then present the deep learning algorithms used to
and explain a few keep DL techniques used to train our con-
volution and deep autoencoder model. Finally, we introduce
several common statistical learning methods that we used
for purposes of comparison with our new deep learning ap-
proaches.
Figure 2: Computational configuration.
Computational Architecture and Dataset
Configuration
To speed up the training process, our hardware configura-
tion included a Nvidia Tesla K80 24GB graphics card with a
28 core Intel Xeon E5 v3 CPU. Python 3 was used with the
TensorFlow machine learning framework, which wrapped in
the high-level Python neural networks library Keras. Other
Python libraries used included Numpy, Pandas, and matlib-
plot. The hardware and software setup is summarized in Fig-
ure 2.
We split the full dataset, using 80% as a training set and
reserving 20% as a testing set after separately randomly
shuffling the data for all cancer and normal datasetsthey
were shuffled separately because of an issue with unbal-
anced data between the two sets.
Unsupervised learning via deep autoencoder
Instead of manually selecting features or reducing the size
of features, in the deep autoencoder approach(Bengio et al. ;
Coates et al. ; Ng et al. 2013), the model learns the feature
representations through coupling encoder layers symmetri-
cally with decoder layers (Figure 3). Both encoder and de-
coder layers are composed of a few shallow layers of deep-
belief networks. The building block of the deep-belief net-
works are restricted Boltzmann machines(Baldi ).
In our approach, we have used five hidden layers with two
encoder layers of 100 and 50 units each, a middle feature
representation vector of 25 units, and two decoding layers
with 50 and 100 units each. After training for 1000 epochs
on the training data, we extracted the encoder layers and
transformed them to a fully connected neural network with
multi-classification as its output (Figure 4). Traditionally,
the first encoding layer will have a higher number of units
(nodes) than the input layer; however, since the number of
our input layer is already greater than 60,000, we decided to
use 100 units instead, the same as for the last decoding layer.
Figure 3: Deep autoencoder structure.
The deep autoencoder essentially tries to learn a function
h(W,b)(X) ≈ X , where X is input, in this case, the gene
expression data. In other words, it is trying to approximate
the identity function with output Xˆ that is close to X(Vin-
cent et al. 2010). Through training, the model will learn the
best compressed feature representation vector that can be de-
coded, or reconstructed, back into the original input. In this
case, it eventually achieved a low-dimensional representa-
tion very similar to that achieved with PCA, but unlike PCA,
the autoencoder is a nonlinear approach. The resulting fea-
ture representation vector captured the non-linearity of the
relationship between expression of different genes.
The idea of fit the X here we represent as normalized in-
put that scaled into [0, 1] to the deep encoder model and out-
put a result Xˆ similar to the input X , is to minimize the
cross entropy between the input and output of the deep au-
toencoder:
L(X, Xˆ) = −
n∑
k=1
[xk log xˆk + (1− xk) log 1− xˆk]
The output Xˆ is from the formula:
Xˆ = h(W, b(X) = σ(W
Tσ(Wx+bencode)
{l}+bdecode){l}
where σ(s) = 11+e−s , W ∈ IRn×m (l is the number of
encoder/decoder layer, n the sample dimension, and m the
number of neurons in each layer), ben/de−coder,l ∈ IR.
Supervised transform learning with a neural
network
In order to perform the cancer detection and type classifi-
cation, we froze the encoder layers learned from the deep
autoencoder step and transformed them to a fully connected
neural network, as shown in Figure 4. The fully connected
neural network is formed by stacking layers of neurons to-
gether. It includes three types of layers: an input layer, which
is the output from the encoding layers of the deep autoen-
coder model, hidden layers, and an output layer. The neural
network learns by adjusting weights through forward and
backward propagation. Each neuron, or node, in the hidden
layers uses a ReLU activation to achieve nonlinearity. Us-
ing labels provided by the data allows supervised learning
to train the classifier. For the single-class classification, we
Figure 4: Transform learning: using the feature representa-
tion vector from the autoencoder as the input of the multi-
classification neural network.
Figure 5: Machine and Statistical Learning with PCA.
used a logistic classifier, and for multiple-class classifica-
tion, we chose a SoftMax classifier.
Machine and Statistical Learning with PCA
For purposes of comparison, we also employed other ma-
chine and statistical learning techniques to analyze the gene
expression data. Similarly, normalized and shuffled training
data were first put through a dimension reduction phase, as
shown in Figure 5. The resulting extracted features are sim-
ply a linear function of the original input data, which lost
all non-linearity of the relations between expressions of dif-
ferent genes(Raina et al. 2007). Using the top 40 principle
components from the dimension reduction, we further fit
five machine and statistical learning models: linear discrim-
inant analysis (LDA), neural network, K-nearest neighbor,
random forest, and extremely randomized tree.
Results and Discussion
To demonstrate the feasibility and applicability of our pro-
posed method we show the classification results for the test-
ing data set (20% of the total data). Since all comparison
models that use PCA for dimension reduction can only ap-
ply to a single classification task, we tested our proposed
method against comparison models only for the lung can-
cer datasince the lung cancer dataset is the only one with
balanced sample sizes between the cancer and normal la-
bels. The first three principle components from the PCA are
visualized in Figure 6 and the classification comparison re-
sults are shown in Figure 7. The first three principle compo-
nents illustrated in Figure 6 capture the most variate data and
should, in theory, exhibit a clear separation between normal
Figure 6: First three principle components for lung cancer
training dataset.
Table 1: Classification results from the different machine
and statistical learning models.
Method Accuracy FPR FNR
PCA-LDA 98.30% 3.42% 0.48%
PCA-Neural
Network 97.17% 3.42% 2.42%
PCA-K Nearest
Neighbor 95.75% 3.42% 4.83%
PCA-Random
Forest 96.60% 6.16% 1.45%
PCA-Extremely
Randomized Tree 97.17% 4.79% 1.45%
and cancer labels; however, almost all the data points min-
gled together at the bottom left of the figure. This suggests
two important points: first, the linear function of the PCA
is probably unable to capture the non-linearity of the data,
and second, the classification power could not improve for
the rest of the components, which have much lower eigen-
values, and so capture less variation.
As shown in Table 1, we achieved quite high accuracy us-
ing the PCA approach with different classification modes.
The best model was the PCA + LDA, with 98.30% accu-
racy; however, this is still not as good as the result from our
proposed deep autoencoder approach. In addition, all PCA
models had a high false positive rate (FPR) and false neg-
ative rate (FNR). For disease detection, the focus is on low
FNR, especially since we do not want to predict a negative
report when patient has cancer and thereby delay necessary
treatment. Figure 7 shows the classifications from the deep
autoencoder + neural network model. On the left of the fig-
ure is the confusion matrix without normalizationthere, the
values are counts of casesand on the right are the normal-
ized results as percentages. The results show our approach
Figure 7: Classification results for the proposed deep autoen-
coder approach.
Figure 8: Multi-classification results of the proposed autoen-
coder model.
outperforms all the PCA models, with both high accuracy
and very low FNR and FPR.
By applying the multi-classification approach, we were
able to construct an overall model for classifying 33 disease
types (32 cancers + normal). In Figure 8, the background
color, ranging from dark blue to white, represents the abun-
dance of the data. In the perfect scenario, all diagonal el-
ements of the confusion matrix should be 1, representing
100% correction. In our case, the majority of the diagonal
elements have high values and low FNR (suggest from the
values in the non-diagonal elements). However, three can-
cers, LGG, UVM, and LUSC, all have a high misclassifica-
tion rate, and GBM has a 100% false negative rate.
All four problematic cancer types (LGG, low-grade
glioma; UVM, uveal melanoma; LUSC, lung squamous cell
carcinoma; and GBM, glioblastoma multiforme) had a very
low sample abundance, with sample sizes much below 100
(some less than 50). This suggest the classification problem
could root from the model being unable to learn, or extract,
useful information from the data. Secondly, three of these
cancers (LGG, UVM and GBM) are neural diseases. The
metabolism of neural tissue is different than that of other
tissues; therefore, the gene expression data might unable to
capture the full pattern of the cancer. LUSM is the only
one misclassified to many types with a low FPR; it occurs
when abnormal lung cells multiple out of control and even-
tually spread (metastasize) to other tissues. This information
helps explain that these type of cancer cells need to disguise
themselves as other tissue types to metastasize; therefore,
the gene expression pattern might be similar to the corre-
sponding tissue type, causing it to be easily misclassified.
Conclusion
In this paper, we propose a method to facilitate cancer detec-
tion and type classification from gene expression data using
a deep autoencoder and neural network. Unlike traditional
feature selection approaches, the method detailed here uses
an autoencoder to automatically generate feature representa-
tions, thus addressing the very high dimensionality of gene
expression data. This extracted feature vector captures the
non-linearity of the data, is scalable for new data after train-
ing, and is able to generalize in multi-classification of dif-
ferent types of cancer. The results show that for cancer de-
tection, a single-classification task, the proposed model can
achieve higher accuracy and lower false positive and neg-
ative rate than traditional algorithms. For cancer type clas-
sification, a multi-classification task, it performs very well
when sufficient sample data are available to train the model.
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